ANNA PATTERSON: Open Payments
NPI 1679076046 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 28 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $578 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $170 |
| Novo Nordisk Inc | 5 | $118 |
| Medtronic, Inc. | 1 | $90 |
| Xeris Pharmaceuticals, Inc. | 4 | $73 |
| Ascendis Pharma Endocrinology Inc | 3 | $61 |
| Abbott Laboratories | 2 | $43 |
| Corcept Therapeutics | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Lilly USA, LLC | 1 | $20 |
| Sequel Med Tech, LLC | 1 | $18 |
Products named: MINIMED 780G, Ozempic, Yorvipath, GVOKE HYPOPEN, Rybelsus, FREESTYLE LIBRE 3, Korlym, Kerendia.
Industry payments across GA — which companies pay providers there.
